A Randomized, Double-Blinded, Phase II Trial of Gemcitabine and Nab-Paclitaxel Plus Apatorsen or Placebo in Patients with Metastatic Pancreatic Cancer: The RAINIER Trial. [electronic resource]
Producer: 20180723Description: 1427-e129 p. digitalISSN:- 1549-490X
- Adult
- Aged
- Albumins -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- Deoxycytidine -- administration & dosage
- Disease-Free Survival
- Female
- HSP27 Heat-Shock Proteins -- antagonists & inhibitors
- Humans
- Kaplan-Meier Estimate
- Male
- Middle Aged
- Oligonucleotides, Antisense -- administration & dosage
- Paclitaxel -- administration & dosage
- Pancreatic Neoplasms -- blood
- Prognosis
- Treatment Outcome
- Gemcitabine
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.